The global thymosin market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market include Ongoing research and clinical trial and their results associated with the application of thymosin in many medical conditions, and the growing burden of Hepatitis A virus (HAV) and hepatitis B virus (HBV) across the globe. Thymosin is the hormone secreted by the thalamus and its primary function is to stimulate the production of T-cells that are an important part of the immune system. Additionally, it assists to develop B-cells into plasma cells to produce antibodies. Thymosin (thymalfasin) is indicated as monotherapy or combination therapy with interferon for the treatment of chronic hepatitis B and C. 

In addition, growing R&D activities regarding thymosin and clinical trials for thymosin are fuelling the growth of the market. Many pharmaceutical and biotechnological companies are investing in clinical trials and drug development activities of thymosin, which is further escalating the market. The government initiatives and funding for new drug development is also expected to support the R&D in thymosin. Furthermore, the increasing number of patients with colorectal cancer and the ability of thymosin to cure such type of cancer is augmenting the growth of the market. Thymosin is indicated as adjuvant therapy for chemotherapy-induced immune depression, immune suppression and immune insufficiency in patients with non-small cell lung carcinoma (NSCLC). Additionally, it is used in colorectal cancer, head and neck cancer, leukaemia’s, pancreatic carcinoma, renal cell carcinoma, malignant melanoma, hepatocellular carcinoma (HCC), breast cancer and non-Hodgkin’s lymphoma (CHOP program). These factors are contributing towards driving the growth of the global thymosin market.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: F.Hoffman La-Roche AG, Merck KGaA, and Gilead Sciences, Inc., among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Thymosin Market Report Segmentation

By Type 

• Thymosin Alpha-1

• Thymosin Alpha-2, 

• Thymosin Beta-4

By Application 

• Emphysema

• Motor Neurone Disease

• Malnutrition

• Diabetes

• Infection

• Cancer

• Hair Loss

• Wound Healing 

• Other

Global Thymosin Market by Region